文献速递前列腺增生与排尿功能障碍

女性尿道狭窄腹侧嵌入颊黏膜移植尿道成形术的长期随访与成功率

Long-term Follow-up and Success Rate of Ventral Inlay Buccal Mucosal Graft Urethroplasty for Female Urethral Stricture Disease.
PubMed 文献 · Urology · 2022-05-17

回顾性分析2016年5月至2020年1月接受腹侧嵌入颊黏膜移植尿道成形术(Vi-BMGU)的女性尿道狭窄患者21例,随访至少2年,中位随访42个月。总体成功率90.5%,术后1年成功率95%,2至5年维持85%。

要点

  • Vi-BMGU术后1年成功率为95%,2至5年维持85%。
  • 21例中2例失败,分别发生于术后6个月和24个月。
  • 无患者出现尿失禁,AUA评分、Qmax和PVR在除3例外的患者中均改善。

核心结论

  • Vi-BMGU术后1年成功率95%、2至5年随访维持85%的成功率,确立了该术式的长期成功性。

研究设计与样本

  • 回顾性分析前瞻性维护的数据,纳入2016年5月至2020年1月接受Vi-BMGU且随访至少2年的女性尿道狭窄患者21例。
  • 主要结局为术后2至5年的长期成功率。
  • 随访包括美国泌尿外科学会(AUA)症状评分、尿流率测定和排尿后残余尿(PVR)测定。
  • 失败(复发)定义为后续随访AUA症状评分增加3分且最大尿流率(Qmax)<12 cc/s且无法用18 Fr导管校准。

主要发现

  • 中位随访42个月(范围24-64个月)。
  • 中位AUA评分从诊断时27分(范围18-34)降至末次随访时9分(范围6-24)。
  • 中位PVR从138 ml(范围34-290)降至24 ml(范围19-360)。
  • 平均Qmax从7.7 ± 2.2 ml/s改善至22.6 ± 5 ml/s。
  • 共2例失败,1例发生于6个月、另1例发生于24个月;总体成功率为90.5%。

关键数值与推荐

  • 失败(复发)判定标准:AUA症状评分增加3分且Qmax<12 cc/s且无法用18 Fr导管校准。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the long-term success of ventral inlay buccal-mucosal graft urethroplasty (Vi-BMGU) for female urethral strictures (FUS). MATERIALS AND METHODS: We performed a retrospective analysis of prospectively maintained data on patients who underwent Vi-BMGU between May 2016 and January 2020 with a minimum follow-up of 2 years. The primary outcome was the long-term success after 2 to 5 years of surgery. Patients were followed with American Urological Association (AUA) symptom score, uroflowmetry, and post-void residual (PVR) urine measurement. Failure (recurrence) was defined by an increase in the AUA symptoms score by 3 on subsequent follow-up visits and maximum flow rate (Qmax) <12 cc/s and inability to calibrate with an 18 Fr catheter. RESULTS: Twenty-one patients were included. The Median follow-up was 42 months (range: 24-64 months). The AUA symptom scores, Qmax, and PVR, improved in all except 3 patients. The median AUA score fell from 27 (range 18-34) at diagnosis to 9 (range 6-24), at the last follow-up. Similarly, the median PVR values decreased from 138 ml (34-290) to 24 ml (19-360) and the mean Qmax improved from 7.7 ± 2.2 ml/s to 22.6 ± 5 ml/s. None experienced urinary incontinence. There were 2 failures, 1 at 6 months and the other at 24 months. The overall success rate was 90.5 %. Success rates on life table analysis were 95%, 85%, 85%, 85%, and 85% after 1, 2, 3, 4 and 5 years respectively. CONCLUSION: The 95% success at 1 year and 85% sustained success at 2 to 5 years of follow-up establishes the long-term success of Vi-BMGU.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Kumaraswamy S, Mandal S, Das MK, et al. Long-term Follow-up and Success Rate of Ventral Inlay Buccal Mucosal Graft Urethroplasty for Female Urethral Stricture Disease. Urology. 2022. PMID: 35588789. doi:10.1016/j.urology.2022.05.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。